Vanda VP-VEC-162-3108
A Multicenter, Double-Blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
- Sex: Any
- Age: Child (Birth - 17)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase III
- Conditions Being Studied:
Study Purpose
The purpose of this research study is to investigate a potential treatment to address sleep difficulties in children with insomnia disorder. This study is being conducted to determine if tasimelteon, when taken daily at bedtime, can help improve nighttime sleep in children with insomnia disorder. This study may also help researchers learn more about the safety of tasimelteon.
Who Can Participate
Ages: 2-17 years old
Locations
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106
UH Beachwood Medical Center
25501 Chagrin Blvd
Beachwood OH, 44122
UH Parma Medical Center
7007 Powers Blvd
Parma OH, 44129
- UH IRB: STUDY20241215
- StudyID: 2024-01589
- ClinicalTrials.gov: N/A
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422